Search research articles
Contact Us
Filters
Showing results (71-80 of 94) with videos related to
Page
of 10
Sort By:
American Journal of Hematology
|
March 31, 2012
A shorter time to the first treatment may be predicted by the absolute number of regulatory T-cells in patients with Rai stage 0 chronic lymphocytic leukemia
Giovanni D'Arena, Fiorella D'Auria, Vittorio Simeon, et al.
Leukemia & Lymphoma
|
October 15, 2016
Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia
Luciana De Luca, Giovanni D'Arena, Vittorio Simeon, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
October 21, 2016
MicroRNA-155 in serum-derived extracellular vesicles as a potential biomarker for hematologic malignancies - a short report
Antonella Caivano, Francesco La Rocca, Vittorio Simeon, et al.
British Journal of Haematology
|
May 11, 2011
Common genetic variation at 15q25.2 impacts on chronic lymphocytic leukaemia risk
Dalemari Crowther-Swanepoel, Maria Chiara Di Bernardo, Krzysztof Jamroziak, et al.
Blood
|
September 27, 2013
CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism
Antonella Zucchetto, Chiara Caldana, Dania Benedetti, et al.
Haematologica
|
October 30, 2020
<i>SF3B1</i>-mutated chronic lymphocytic leukemia shows evidence of NOTCH1 pathway activation including CD20 downregulation
Federico Pozzo, Tamara Bittolo, Erika Tissino, et al.
European Journal of Haematology
|
June 25, 2017
Prognostic relevance of oxidative stress measurement in chronic lymphocytic leukaemia
Giovanni D'Arena, Candida Vitale, Omar Perbellini, et al.
Hematological Oncology
|
March 31, 2018
CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia
Giovanni D'Arena, Candida Vitale, Giovanni Rossi, et al.
American Journal of Hematology
|
September 29, 2011
The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: a retrospective multicentric GIMEMA experience
Luca Laurenti, Michela Tarnani, Ilaria Nichele, et al.
Leukemia & Lymphoma
|
April 4, 2017
Adverse drug reactions after intravenous rituximab infusion are more common in hematologic malignancies than in autoimmune disorders and can be predicted by the combination of few clinical and laboratory parameters: results from a retrospective, multicenter study of 374 patients
Giovanni D'Arena, Vittorio Simeon, Luca Laurenti, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 94) with videos related to
Sort By:
Page
of 10
American Journal of Hematology
|
March 31, 2012
A shorter time to the first treatment may be predicted by the absolute number of regulatory T-cells in patients with Rai stage 0 chronic lymphocytic leukemia
Giovanni D'Arena, Fiorella D'Auria, Vittorio Simeon, et al.
Leukemia & Lymphoma
|
October 15, 2016
Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia
Luciana De Luca, Giovanni D'Arena, Vittorio Simeon, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
October 21, 2016
MicroRNA-155 in serum-derived extracellular vesicles as a potential biomarker for hematologic malignancies - a short report
Antonella Caivano, Francesco La Rocca, Vittorio Simeon, et al.
British Journal of Haematology
|
May 11, 2011
Common genetic variation at 15q25.2 impacts on chronic lymphocytic leukaemia risk
Dalemari Crowther-Swanepoel, Maria Chiara Di Bernardo, Krzysztof Jamroziak, et al.
Blood
|
September 27, 2013
CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism
Antonella Zucchetto, Chiara Caldana, Dania Benedetti, et al.
Haematologica
|
October 30, 2020
<i>SF3B1</i>-mutated chronic lymphocytic leukemia shows evidence of NOTCH1 pathway activation including CD20 downregulation
Federico Pozzo, Tamara Bittolo, Erika Tissino, et al.
European Journal of Haematology
|
June 25, 2017
Prognostic relevance of oxidative stress measurement in chronic lymphocytic leukaemia
Giovanni D'Arena, Candida Vitale, Omar Perbellini, et al.
Hematological Oncology
|
March 31, 2018
CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia
Giovanni D'Arena, Candida Vitale, Giovanni Rossi, et al.
American Journal of Hematology
|
September 29, 2011
The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: a retrospective multicentric GIMEMA experience
Luca Laurenti, Michela Tarnani, Ilaria Nichele, et al.
Leukemia & Lymphoma
|
April 4, 2017
Adverse drug reactions after intravenous rituximab infusion are more common in hematologic malignancies than in autoimmune disorders and can be predicted by the combination of few clinical and laboratory parameters: results from a retrospective, multicenter study of 374 patients
Giovanni D'Arena, Vittorio Simeon, Luca Laurenti, et al.
Page
of 10